Seres Therapeutics, Inc. Interest Income, Other
Seres Therapeutics, Inc. (MCRB) reported Interest Income, Other of $349.00 thousand for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-02.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2018-08-02
- Seres Therapeutics, Inc. interest income, other for the quarter ending 2018-06-30 was $349.00K, a 43.25% decline year-over-year.
- Seres Therapeutics, Inc. interest income, other for the quarter ending 2017-09-30 was $502.00K, a 30.18% decline year-over-year.
- Seres Therapeutics, Inc. interest income, other for the quarter ending 2017-06-30 was $615.00K, a 24.24% increase year-over-year.
- Seres Therapeutics, Inc. interest income, other for the quarter ending 2017-03-31 was $775.00K, a 189.18% increase year-over-year.
- Seres Therapeutics, Inc. interest income, other for fiscal 2016 was $2.23M, a 249.37% increase from fiscal 2015.
- Seres Therapeutics, Inc. interest income, other for fiscal 2015 was $638.00K.
| Period end | Interest Income, Other 3 month | Interest Income, Other 3 month as first filed | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month |
|---|---|---|---|---|---|
| 2018-06-30 | $349.00K 10-Q · filed 2018-08-02 | $696.00K 10-Q · filed 2018-08-02 | |||
| 2017-09-30 | $502.00K 10-Q · filed 2017-11-08 | $1.12M derived: sum of 2 quarters · filed 2018-08-02 | $1.89M 10-Q · filed 2017-11-08 | $2.64M derived: sum of 4 quarters · filed 2018-08-02 | |
| 2017-06-30 | $615.00K 10-Q · filed 2018-08-02 | $1.39M 10-Q · filed 2018-08-02 | $2.14M derived: sum of 3 quarters · filed 2018-08-02 | $2.85M derived: sum of 4 quarters · filed 2018-08-02 | |
| 2017-03-31 | $775.00K 10-Q · filed 2017-05-04 | $1.52M derived: sum of 2 quarters · filed 2017-05-04 | $2.24M derived: sum of 3 quarters · filed 2017-11-08 | $2.73M derived: sum of 4 quarters · filed 2017-11-08 | |
| 2016-12-31 | $746.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $1.47M derived: sum of 2 quarters · filed 2017-11-08 | $1.96M derived: sum of 3 quarters · filed 2017-11-08 | $2.23M 10-K · filed 2017-03-16 | |
| 2016-09-30 | $719.00K 10-Q · filed 2017-11-08 | $1.21M derived: sum of 2 quarters · filed 2017-11-08 | $1.48M 10-Q · filed 2017-11-08 | $1.75M derived: sum of 4 quarters · filed 2017-11-08 | |
| 2016-06-30 | $495.00K 10-Q · filed 2017-08-03 | $763.00K 10-Q · filed 2017-08-03 | $1.03M derived: sum of 3 quarters · filed 2017-08-03 | $1.20M derived: sum of 4 quarters · filed 2017-08-03 | |
| 2016-03-31 | $268.00K 10-Q · filed 2017-05-04 | $534.00K derived: sum of 2 quarters · filed 2017-05-04 | $706.00K derived: sum of 3 quarters · filed 2017-05-04 | $754.00K derived: sum of 4 quarters · filed 2017-05-04 | |
| 2015-12-31 | $266.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $438.00K derived: sum of 2 quarters · filed 2017-03-16 | $486.00K derived: sum of 3 quarters · filed 2017-03-16 | $638.00K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $172.00K 10-Q · filed 2016-11-10 | $220.00K derived: sum of 2 quarters · filed 2016-11-10 | $372.00K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $199.00K 10-Q · filed 2016-08-11 | |||
| 2015-03-31 | $151.00K 10-Q · filed 2016-08-11 | $49.00K 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |